Fig. 2From: Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia/lymphoma (ATLL): a systematic review and meta-analysisThe pooled estimate of the overall response rate (OR) of ATLL patients receiving an Zidovudine and Interferon Alfa based regimens (AZT/IFN) during their therapeutic interventionBack to article page